Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli

Pathogenic Escherichia coli can cause fatal diarrheal diseases in both animals and humans. However, no antibiotics or antimicrobial peptides (AMPs) can adequately kill resistant bacteria and clear bacterial endotoxin, lipopolysaccharide (LPS) which leads to inflammation and sepsis. Here, the LPS-tar...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Commun Biol
Glavni autori: Wang, Zhenlong, Liu, Xuehui, Da Teng, Mao, Ruoyu, Hao, Ya, Yang, Na, Wang, Xiao, Li, Zhanzhan, Wang, Xiumin, Wang, Jianhua
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6978316/
https://ncbi.nlm.nih.gov/pubmed/31974490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-020-0761-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items